Trials / Not Yet Recruiting
Not Yet RecruitingNCT06382038
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism:A Multicenter, Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,972 (estimated)
- Sponsor
- Navy General Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention. The objective of this study is to evaluate the impact of mobile venous thromboembolism application (mVTEA) based patient-centered management of pulmonary thromboembolism (PTE) on the long-term outcome of PTE patients, in order to enhance clinical practice and establish a foundation of evidence for managing patients with PTE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | mobile venous thromboembolism application (mVTEA) | mVTEA will assist in the management of patients during the post-hospitalization follow-up phase. The mVTEA's doctor terminal automatically sends venous thromboembolism (VTE)-related health education materials in different frequencies and contents based on the patient's knowledge of VTE prevention and treatment, as well as their risk of thrombosis and bleeding during follow-up. In addition, thrombosis physicians on the mVTEA's doctor terminal can deliver health education to patients based on their condition. This can be done through the mVTEA doctor-patient communication module, which includes text, voice, and video communication. |
Timeline
- Start date
- 2025-10-08
- Primary completion
- 2026-10-31
- Completion
- 2026-10-31
- First posted
- 2024-04-24
- Last updated
- 2025-05-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06382038. Inclusion in this directory is not an endorsement.